-
I sometimes use bowtie2 for the alignment stage of running RSEM (RNA-Seq gene expression). RSEM didn't allow INDELS in the alignments so as part of tweaking bowtie2 to not report those I was advised to set '--dpad 0'. -
Sorry the first explanation I posted was from bowties implemented command line help. The following description was actually taken from the manual:
--dpad <int>
“Pads” dynamic programming problems by <int> columns on either side to allow gaps. Default: 15.Leave a comment:
-
bowtie 2 dpad parameter explanation
Can someone provide a detailed explanation, what the bowtie2 parameter "--dpad" does? The explanation given in the manual is as follows: "--dpad <int> include <int> extra ref chars on sides of DP table (15)".
I would interprete it like this:
1) A sequence string of length <int> is attached to every 5' and 3' end of a read after seeding and global alignment.
2) Attached sequences are used to solve mapping issues at readends (e.g. deletions present at readends that have been falsley softclipped in previous steps).
!!!But I am really not confident with this!!!
I am asking because I realised that increasing dpad to an integer of 100, solves issues I have to face with large deletions in a merged 350bp Illumina amplicon dataset. I mean solving this issue is fine, but I do not have a clue what the possible drawbacks of this setting might be. Furthermore, as I do not exactly understand the parameter and its behaviour, I do not know how to test for possible side-effects.
Here are my option settings:
bowtie2 --rdg 5,1 --rfg 5,1 --dpad 100 --score-min L,0,-0.75 --very-sensitive
-
CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).
Despite this, “CRISPR helped turn genome editing from a specialized technique into...07-31-2026, 11:01 AM -
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...07-20-2026, 11:48 AM -
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...07-09-2026, 11:10 AM
Leave a comment: